{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:40:06Z","timestamp":1769308806026,"version":"3.49.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background\/Purpose:<\/jats:title>\n            <jats:p>To report the largest case series to date of uveitis occurring in association with immunomodulatory therapy for malignant melanoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective multicenter case review. Twenty-two patients with uveitis occurring in association with either immunotherapy or targeted immune therapy for malignant melanoma were identified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 22 patients, 11 had anterior uveitis in isolation. The remainder showed a variety of clinical features including panuveitis, ocular hypotony, papillitis, cystoid macular edema, and melanoma-associated retinopathy. Most patients responded well to treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>We report the largest case series to date of patients with uveitis secondary to drug treatment for malignant melanoma. These cases are likely to increase in number in the future as newer immunomodulatory therapies for cancers are developed and the indications for these drugs increase. A dilemma arises when patients respond well to these drugs but develop vision-threatening side effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0000000000000876","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T16:33:22Z","timestamp":1562603602000},"page":"718-723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["UVEITIS CAUSED BY TREATMENT FOR MALIGNANT MELANOMA: A CASE SERIES"],"prefix":"10.1097","volume":"15","author":[{"given":"Eline","family":"Whist","sequence":"first","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Symes","sequence":"additional","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"},{"name":"Save Sight Institute, Faculty of Medicine and Health, Sydney University, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Chang","sequence":"additional","affiliation":[{"name":"Retina and Vitreous Centre, Strathfield, New South Wales, Australia;"},{"name":"School of Medical Sciences, University of New South Wales, Sydney, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Crows Nest Eye Surgery, Crows Nest, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Anne","family":"Lim","sequence":"additional","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Grigg","sequence":"additional","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"},{"name":"Save Sight Institute, Faculty of Medicine and Health, Sydney University, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Lee","family":"Lin","sequence":"additional","affiliation":[{"name":"Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Karaconji","sequence":"additional","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Giblin","sequence":"additional","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Symons","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital, Parkville, Victoria, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndell L.","family":"Lim","sequence":"additional","affiliation":[{"name":"Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia;"},{"name":"Royal Melbourne Hospital, Parkville, Victoria, Australia; and"},{"name":"Centre for Eye Research Australia, University of Melbourne, Victoria, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"McCluskey","sequence":"additional","affiliation":[{"name":"Sydney Eye Hospital, Sydney, New South Wales, Australia;"},{"name":"Save Sight Institute, Faculty of Medicine and Health, Sydney University, Sydney, New South Wales, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250507","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"R2-20250507","first-page":"237","article-title":"Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma","volume":"11","author":"Kim","year":"2014","journal-title":"Cancer Biol Med"},{"key":"R3-20250507","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ajo.2014.07.003","article-title":"Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib","volume":"158","author":"Choe","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R4-20250507","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S57335","article-title":"Ipilimumab in the treatment of metastatic melanoma: management of adverse events","volume":"7","author":"Della Vittoria Scarpati","year":"2014","journal-title":"Onco Targets Ther"},{"key":"R5-20250507","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jamaophthalmol.2018.0920","article-title":"Uveal effusion after immune checkpoint Inhibitor therapy","volume":"136","author":"Thomas","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R6-20250507","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000439400","article-title":"Sarcoidosis in patients treated with vemurafenib for metastatic melanoma: a paradoxical autoimmune activation","volume":"231","author":"Lheure","year":"2015","journal-title":"Dermatology"},{"key":"R7-20250507","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jcjo.2015.09.008","article-title":"Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: case report","volume":"51","author":"Basilious","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"R8-20250507","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/aos.12678","article-title":"Uveitic macular oedema after treatment with vemurafenib","volume":"93","author":"Fonollosa","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R9-20250507","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-016-0082-3","article-title":"Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma","volume":"6","author":"Hahn","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:16:46Z","timestamp":1746652606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICB.0000000000000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000000876","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}